Core Laboratories (NYSE:CLB) Upgraded at Johnson Rice

Johnson Rice upgraded shares of Core Laboratories (NYSE:CLB) from a hold rating to a buy rating in a report issued on Thursday, MarketBeat reports. The brokerage currently has $21.00 price objective on the oil and gas company’s stock.

Several other equities research analysts also recently issued reports on the stock. Weiss Ratings raised shares of Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, August 3rd. Wall Street Zen raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, August 1st. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $21.00.

Core Laboratories Stock Up 0.7%

Shares of NYSE:CLB opened at $12.48 on Thursday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.12 and a quick ratio of 1.55. The stock has a market cap of $572.54 million, a price-to-earnings ratio of 22.28, a P/E/G ratio of 3.00 and a beta of 1.03. The company has a 50 day moving average of $11.60 and a 200-day moving average of $14.70. Core Laboratories has a one year low of $9.79 and a one year high of $20.36.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, July 29th. The oil and gas company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.02. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%.The business had revenue of $124.61 million during the quarter, compared to the consensus estimate of $126.26 million. During the same quarter in the prior year, the company posted $0.19 earnings per share. The firm’s revenue was down 4.3% on a year-over-year basis. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. On average, sell-side analysts forecast that Core Laboratories will post 0.53 earnings per share for the current year.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Monday, August 10th will be given a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, August 10th. This represents a $0.04 annualized dividend and a yield of 0.3%. Core Laboratories’s dividend payout ratio is 7.14%.

Insiders Place Their Bets

In related news, CEO Lawrence Bruno purchased 5,000 shares of the stock in a transaction on Friday, July 31st. The shares were purchased at an average price of $10.78 per share, with a total value of $53,900.00. Following the transaction, the chief executive officer directly owned 262,438 shares of the company’s stock, valued at $2,829,081.64. This trade represents a 1.94% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.26% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Core Laboratories

Institutional investors have recently added to or reduced their stakes in the company. Summit Securities Group LLC acquired a new stake in Core Laboratories in the first quarter valued at $31,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Core Laboratories in the 4th quarter valued at about $34,000. Quarry LP lifted its stake in Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after purchasing an additional 1,599 shares during the last quarter. CWM LLC grew its holdings in Core Laboratories by 36.1% during the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 668 shares during the period. Finally, Hantz Financial Services Inc. grew its holdings in Core Laboratories by 124.7% during the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after purchasing an additional 1,763 shares during the period. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.